Trevi Therapeutics, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
TRVI Company Description
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
TRVI Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view TRVI Smart Score
Score Breakdown
TRVI Company Description
Show More
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of TRVI by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TRVI's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on TRVI's company Twitter account
WallStreetBets
Number of mentions of TRVI in WallStreetBets Daily Discussion
TRVI News
Recent insights relating to TRVI
CNBC Recommendations
Recent picks made for TRVI stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in TRVI
Corporate Flights
Flights by private jets registered to TRVI
Our Analysis